Palatability and Swallowability of Pimavanserin When Mixed with Selected Food Vehicles: An Exploratory Open-Label Crossover Study
Open Access
- 15 June 2021
- journal article
- research article
- Published by MDPI AG in Geriatrics
- Vol. 6 (2) , 61
Abstract
Dysphagia (difficulty swallowing) affects up to 13% of persons 65 years and older and 51% of older persons in nursing homes and can contribute to reduced adherence to oral medications. This was an exploratory, single-center, open-label, randomized, crossover study in healthy older adult participants. Primary objectives were evaluation of palatability (taste) and swallowability of the contents of pimavanserin 34 mg capsules mixed with selected soft foods or a liquid nutritional supplement. Secondary objectives included evaluation of additional palatability endpoints and ease of capsule manipulation for mixing. A total of 18 healthy, older adult participants (mean age 65 years) were included. Mean participant ratings for all food vehicles were “moderately like” to “neither like nor dislike” for palatability and “very easy” to “somewhat easy” for swallowability. Capsule manipulation to allow sprinkling of contents was rated “very easy” or “somewhat easy” by most participants. There were five treatment-emergent adverse events, all mild; two were deemed related to study treatment. The palatability and swallowability of pimavanserin was considered acceptable when administered with certain soft foods or a liquid nutritional supplement by the study participants.Keywords
Funding Information
- ACADIA Pharmaceuticals Inc. (N/A)
This publication has 21 references indexed in Scilit:
- Dysphagia in Parkinson’s DiseaseDysphagia, 2015
- Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind studyThe Lancet Neurology, 2014
- Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trialThe Lancet, 2014
- Clinical consequences of polypharmacy in elderlyExpert Opinion on Drug Safety, 2013
- Parkinson Disease Affects Peripheral Sensory Nerves in the PharynxJournal of Neuropathology & Experimental Neurology, 2013
- Altered Pharyngeal Muscles in Parkinson DiseaseJournal of Neuropathology & Experimental Neurology, 2012
- Characterization of Oral Disintegrating Film Containing Donepezil for Alzheimer DiseaseAAPS PharmSciTech, 2011
- Review: Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episodeMultiple Sclerosis Journal, 2009
- Pharmacokinetics, Tolerability, and Safety of ACP‐103 Following Single or Multiple Oral Dose Administration in Healthy VolunteersThe Journal of Clinical Pharmacology, 2007
- Neuroleptic-Induced DysphagiaDysphagia, 1997